New functions of stromal proteases and their inhibitors in tumor progression.

Surg Oncol Clin N Am

Laboratory of Tumor and Developmental Biology, University of Liege, Tour de Pathologie, Liege, Belgium.

Published: April 2001

AI Article Synopsis

  • The expression of proteases plays a crucial role in enabling tumors to become invasive and metastatic during cancer progression.
  • The interaction between stromal cells and cancer cells regulates the production of important proteases, like metalloproteinases and serine proteinases.
  • Surprisingly, higher levels of protease inhibitors are linked to worse survival outcomes in cancer patients, indicating that their role in tumor progression is more complex than previously thought.

Article Abstract

Acquisition of invasive metastatic potential through protease expression is a key event in tumor progression. In carcinomas, the production of metalloproteinases and serine proteinases is regulated by a cross talk between stromal cells and cancer cells. Paradoxically, high rather than low levels of their inhibitors predict poor survival of patients suffering from a variety of cancers. Recent observations suggest a much more complex role of these inhibitors in tumor progression than expected initially.

Download full-text PDF

Source

Publication Analysis

Top Keywords

tumor progression
12
inhibitors tumor
8
functions stromal
4
stromal proteases
4
proteases inhibitors
4
progression acquisition
4
acquisition invasive
4
invasive metastatic
4
metastatic potential
4
potential protease
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!